Bigul

Mukka Proteins Ltd - 544135 - Newspaper Advertisement Pursuant To Regulation 47 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

We are hereby enclosing copies of Newspaper Advertisement of Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended 31st March 2024.
16-05-2024
Bigul

Q4FY24 Quarterly & FY24 Annual Result Announced for Mukka Proteins Ltd.

Food Products company Mukka Proteins announced Q4FY24 & FY24 results: PAT for Q4 FY24, increased by 141.53% to Rs 29.15 crore from 12.07 crore in Q3FY24 (QoQ comparison) and increased by 32.99% in Q4FY24 from Rs 21.92 crore in Q4FY23 (YoY comparison) For the entire FY24, PAT increased by 56.35% to Rs 74.31 crore, from Rs 47.52 crore in FY23 On a QoQ basis, the EBITDA margins increased by 177.47%, to 14.38% in Q4FY24 from 5.18% in Q3FY24, indicating 920 bps improvement in the margins EBIDTA has improved by 37.77% to Rs 36.92 crore in Q4FY24 from Rs 26.80 crore in Q3FY24 PAT % as a % of Revenue has improved by 386.44%, to 11.36% in Q4FY24 from 2.33% in Q3FY24 and has improved by 117.96% compared to Q4FY23. On this occasion, Mohammed Haris, MD and CEO, Mukka Proteins said "We are extremely proud of the strong operational performance of the company in Q4FY24. The improvement in the margins clearly indicates that the management is focused on improving the profitability going forward as well. The use of IPO proceeds in the working capital requirements has boarded extremely well with the plans visualized by the management of the company. The sector promises to witness strong growth momentum going further in FY25 and in recent times the support from the Government through various schemes like Pradhan Mantri Matsya Sampada Yojana (PMMSY), Fisheries and Aquaculture Infrastructure Development Fund, Blue revolution 2.0 will only boost the prospects of the industry going forward. Our aim will be to surpass the industry growth and ensure that all our stakeholders including investors are extremely happy with the company’s performance”. Result PDF
15-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

We are enclosing herewith the Monitoring Agency Report dated May 14, 2024, issued by ICRA Limited for the quarter ended March 31, 2024.
14-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Statement Of Deviation(S) Or Variation(S) Of Funds Raised Through Initial Public Offer (''IPO'') For The Quarter Ended March 31, 2024

Please find enclosed herewith the statement of deviation(s) or variation(s) in utilization of funds raised through IPO for the quarter ended March 31, 2024.
14-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March 2024.

Audited financial results for the quarter and year ended 31st March 2024.
14-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Audited Financial Results For The Quarter And Year Ended 31St March 2024.

Audited financial results for the quarter and year ended 31st March 2024.
14-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Board Meeting Intimation for Intimation Of Board Meeting.

Mukka Proteins Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2024 ,inter alia, to consider and approve We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 14th May 2024, inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2024.
06-05-2024
Bigul

Mukka Proteins Ltd - 544135 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Mukka Proteins Ltd 2 CIN NO. 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2022-23, 2023-24 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2022-23, 2023-24 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Mehaboobsab Mahmadgous ChalyalDesignation :-Company Secretary Compliance Officer Name of the Chief Financial Officer :- Kalandan Mohammed Althaf Designation : -Whole Time Director CFO Date: 30/04/2024
30-04-2024
Bigul

Mukka Proteins Ltd - 544135 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMukka Proteins Ltd 2CIN NO. 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 5.57 4Highest Credit Rating during the previous FY BBB+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Mehaboobsab Mahmadgous Chalyal Designation: Company Secretary Compliance Officer EmailId: [email protected] Name of the Chief Financial Officer: Kalandan Mohammed Althaf Designation: Whole Time Director CFO EmailId: [email protected] Date: 30/04/2024 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
30-04-2024
Next Page
Close

Let's Open Free Demat Account